Olimel N12e (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

The mixture provides the building blocks required for protein synthesis. Once infused, the amino acids are taken up by cells, incorporated into new proteins, and help restore nitrogen balance, support tissue repair, and maintain metabolic functions in patients lacking enteral intake.

The dose of Olimel N12e is individualized. A qualified prescriber determines the volume and rate of infusion based on the patient’s weight, clinical condition, renal and hepatic function, and overall nutritional requirements.

Safety data for Olimel N12e in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under close medical supervision.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required), and import documentation.

Olimel N12e offers a balanced profile of ten essential amino acids in a single formulation, matching the composition of many reference products used in Europe. Compared with some alternatives that contain additional non‑essential amino acids or different ratios, Olimel N12e is designed for straightforward dosing and compatibility with standard parenteral nutrition regimens.

Olimel N12e must be stored refrigerated at 2‑8 °C. Keep the container in its original packaging, protect it from light, and avoid freezing or shaking. Before use, inspect the solution for particulate matter or discoloration and follow aseptic technique during preparation.

The product is administered intravenously as an infusion. It should be added to a compatible carrier solution, mixed under sterile conditions, and infused at a rate prescribed by the treating clinician, typically using an infusion pump to ensure accurate delivery.

Serious risks include severe hyperammonemia, anaphylactic reactions, significant electrolyte disturbances (such as hyperkalemia or hyperphosphatemia), and renal impairment. Patients should be monitored closely for these events, especially during the initial infusion period.

Olimel N12e is contraindicated in individuals with known hypersensitivity to any of its amino acid components. It should also be used with caution, or avoided, in patients with severe renal failure, uncontrolled electrolyte abnormalities, or those receiving incompatible intravenous solutions.